Why the FDA is really going after NAC...
Because it defeats COVID...
N-Acetylcysteine to Combat COVID-19: An Evidence Review
Zhongcheng Shi1,2 and Carlos A Puyo3
https://www.ncbi.nlm.nih.gov/pmc/art...WX19KipSU2mabkConclusions
N-acetylcysteine (NAC) is inexpensive, has very low toxicity, has been FDA approved for many years, and has the potential to improve therapeutic strategies for COVID-19. NAC administered intravenously, orally, or inhaled, may suppress SARS-CoV-2 replication and may improve outcomes if used timely. Potential therapeutic benefits of NAC include, extracellularly scavenging ROS radicals, replenishing intracellular GSH, suppression of cytokine storm, and T cell protection, thus mitigating inflammation and tissue injury. NAC administration in combination with other antiviral agents may dramatically reduce hospital admission rate, mechanical ventilation and mortality.